Abridge

About Abridge

Financials

Dated, source-cited figures. Estimates are marked.

Products by Abridge

All products by Abridge reviewed by our AI panel of experts.

AbridgeAI Healthcare

AI clinical documentation from live patient-clinician conversations

Free8.3/10

How Our Review Panel Scores Abridge

Six independent reviewer personalities assessed Abridge's product on their own terms. They disagreed by 1.6 points — The Finance Lead was the hardest to convince, The Decision Maker the most positive.

Averaged across 1 reviewed product in our catalog. Scores are out of 10.

Competitive Landscape

Who Abridge competes with, and how they differ.

Microsoft (Nuance DAX)7.8/10

Nuance DAX is the incumbent ambient clinical documentation product, deeply integrated with Epic and backed by Microsoft's enterprise sales channel, whereas Abridge is an independent startup competing primarily on model accuracy and specialty-specific note quality.

9 products reviewed on TopReviewed

Nabla8.0/10

Nabla offers a similar ambient AI scribe product but targets a broader international and outpatient/primary-care market with a lighter-weight, faster-to-deploy tool compared to Abridge's enterprise health-system focus.

1 product reviewed on TopReviewed

Suki AI7.8/10

Suki is a voice-first AI assistant for clinical documentation and EHR tasks, competing directly for the ambient scribe market but with a stronger emphasis on voice command workflows beyond note generation.

1 product reviewed on TopReviewed

Notable7.8/10

Notable focuses more broadly on healthcare workflow automation (intake, coding, prior auth) with ambient documentation as one component, versus Abridge's narrower focus on conversation-to-note transcription.

1 product reviewed on TopReviewed

DeepScribe7.7/10

DeepScribe is a direct ambient documentation competitor targeting small-to-mid-size practices with a lower-cost, template-driven approach compared to Abridge's health-system enterprise contracts.

1 product reviewed on TopReviewed

Hippocratic AI7.8/10

Hippocratic AI builds patient-facing conversational AI agents (e.g., for outreach and triage) rather than physician documentation tools, overlapping with Abridge only at the edges of clinical conversation AI.

1 product reviewed on TopReviewed

Company Timeline

Key milestones in Abridge's history, with sources.

1. Jun 11, 2026Partnership

   Strategic partnerships with Eli Lilly and Nvidia announced

   Abridge announced a strategic investment from Eli Lilly and a new collaboration with Nvidia to co-develop the first foundation model purpose-built for clinical conversations.

   statnews.com
2. April 2026Funding

   Series E extension -- $316M at steady $5.3B valuation

   Abridge closed a $316 million Series E extension in April 2026, holding its valuation at $5.3 billion, with backers including NVentures, Nvidia's venture arm.

   fortune.com
3. Jun 24, 2025Funding

   Series E -- $300M led by Andreessen Horowitz, $5.3B post-money valuation

   Abridge raised $300 million in Series E funding led by Andreessen Horowitz with participation from Khosla Ventures, nearly doubling its valuation to $5.3 billion four months after the Series D.

   techcrunch.com
4. Feb 17, 2025Funding

   Series D -- $250M co-led by Elad Gil and IVP, $2.75B post-money valuation

   Abridge raised $250 million in Series D funding co-led by Elad Gil and IVP at a $2.75 billion post-money valuation, coinciding with surpassing 100 health-system deployments and launching a new Contextual Reasoning Engine for billable clinical notes.

   fortune.com
5. Feb 23, 2024Funding

   Series C -- $150M led by Lightspeed Venture Partners and Redpoint Ventures

   Abridge raised $150 million in Series C funding with participation from IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Kaiser Permanente Ventures and CVS Health Ventures.

   abridge.com
6. Oct 6, 2020Funding

   Seed + Series A -- $15M ($5M seed, $10M Series A) led by Union Square Ventures and UPMC

   Abridge announced $15 million across seed and Series A rounds for its early patient-facing app that summarized doctor-patient conversations, ahead of its later pivot to an ambient clinical-documentation product.

   news.crunchbase.com
7. March 2018Founded

   Abridge founded by Dr. Shiv Rao and Sandeep Konam

   Cardiologist Shiv Rao left his UPMC clinical practice in March 2018 to co-found Abridge with CTO Sandeep Konam, building on research from the Pittsburgh Health Data Alliance, a collaboration between the University of Pittsburgh, UPMC, and Carnegie Mellon University.

   news.crunchbase.com